To determine the concentration of carbamazepine in the blood to establish an appropriate dose and to maintain a therapeutic level
At the beginning of treatment to monitor the concentration of the drug in the blood.
When indicated to detect low or high (potentially toxic) concentrations.
A blood sample taken from a vein in your arm
No test preparation is needed.
This test measures the amount of carbamazepine in the blood. Carbamazepine is a drug that is primarily used to treat certain seizure disorders (also called epilepsy), but is also prescribed to stabilize the moods of patients with bipolar disease and to help alleviate some types of nerve pain (e.g trigeminal neuralgia). It may be prescribed by itself or in combination with other antiepileptic drugs.
Carbamazepine levels are monitored because the drug must be maintained within a relatively narrow concentration range. If the level is too low, the patient may experience a recurrence of symptoms (i.e. seizures, mania, or pain) and if the level is too high, the patient may experience increased toxic side effects. This balance can be difficult to achieve for several different reasons:
- Oral doses of carbamazepine are absorbed in the stomach and intestine at widely variable rates.
- Since carbamazepine is metabolised by the liver, anything that affects the function of the liver can affect blood levels of the drug.
- Much of the drug is bound to proteins in the blood plasma, but it is the free portion of the drug that has the therapeutic effect. Conditions that affect the extent of protein binding of the drug may affect therapeutic effectiveness.
- The product of carbamazepine metabolism, carbamazepine-10,11 epoxide, is also an active compound and contributes to the overall effect of the medication.
- Several drugs, if taken in conjunction with carbamazepine, may alter the effect or affect metabolism and blood levels.
Dosages of carbamazepine must be adjusted carefully until a steady concentration in the blood is reached. The actual amount of drug required to reach this steady state will vary from person to person and may change over time.
Carbamazepine is usually monitored long-term because it is prescribed for chronic conditions which require long-term treatment. Seizure disorders affect the brain’s ability to transmit electrical impulses and to regulate nerve activity. During a seizure, a patient may experience changes in consciousness, alterations in sight, smell, and taste, and may experience convulsions (fits). Seizures are associated with acute conditions, such as high fevers and head trauma, and with chronic conditions such as metabolic disorders and brain tumours. In many cases, the cause is not known. The frequency of seizures varies from a single episode, to occasional seizures, to recurrent seizures. Seizures are categorised by the parts of the brain and body that are affected. Carbamazepine is prescribed to help prevent specific types of recurrent seizures, particularly those unresponsive to lithium.
Bipolar disorder is a psychiatric condition that is characterised by cycles of depression and mania that may last for days, weeks, months, or years. During a depressive episode those affected may feel sad, hopeless, worthless, and have thoughts of suicide. During a manic episode, those affected may be extremely happy and excited, irritable, have poor judgment, and participate in risky behaviour. Carbamazepine is prescribed to help even out the moods of the person with bipolar disorder, especially mania.
Trigeminal neuralgia, a condition associated with facial nerve pain and muscle spasms, and paroxysmal choreoathetosis are also sometimes treated with carbamazepine.
How is the sample collected for testing?
A blood sample is obtained by inserting a needle into a vein in the arm.
Is any test preparation needed to ensure the quality of the sample?
No test preparation is needed.
How is it used?
The carbamazepine blood test is requested to check the amount of carbamazepine in the bloodstream and determine whether drug concentrations are in the desired (“therapeutic”) range. Initially, the test may be used to establish the appropriate dose for a particular individual. Depending on the results of the blood test, the dose of drug may be increased or decreased until the blood level reaches the therapeutic range, Subsequent tests are then used to ensure that the level remains in the therapeutic range. If the individual’s health changes, or if they begin taking other drugs which may affect the level of carbamazepine, the test may be used to determine if the dose needs to be adjusted.
A doctor may use the carbamazepine test to help evaluate an individual who is experiencing side-effects or adverse reactions, or if their symptoms have recurred.
The routine carbamazepine test measures “total” carbamazepine, i.e. all the drug in the blood, both ‘free’ and bound to protein. Rarely, a free carbamazepine or a carbamazepine-10,11 epoxide test may be requested with the carbamazepine test to evaluate their contribution to the patient’s medication.
When is it requested?
Carbamazepine tests are requested frequently on commencing treatment, then as needed to ensure that appropriate blood concentrations are maintained. Additional carbamazepine tests may be requested if the dosage of the drug is changed, if a patient starts or stops taking additional medications (to judge their effect, if any, on carbamazepine levels), or if a patient has a recurrence of symptoms such as a seizure, nerve pain, or bipolar mood swings. Once blood concentrations of carbamazepine have stabilized, concentration monitoring may not be necessary, but levels are sometimes monitored at regular intervals to ensure that they remain within the therapeutic range.
The carbamazepine test may also be requested when a patient’s condition does not appear to be responding to therapy . This may be because concentrations may not be high enough, because the patient may not be taking the medication regularly, or the drug may be ineffective for that person.
Carbamazepine tests may also be requested when a patient experiences a troublesome level of side effects and/or develops complications. Side effects that may be seen at any dose but are related to higher concentrations include:
- Uncoordinated movement
- Blurred or double vision
- Nystagmus— an involuntary movement of the eyeball
Other side effects may include:
- A red itchy rash
Carbamazepine can also sometimes cause liver function abnormalities, low blood sodium concentrations, a decrease in white blood cells (WBCs) or an increase in eosinophils (a type of WBC). In some cases, the severity of side effects may cause the patient and doctor to select a different medication for the disorder being treated.
A free carbamazepine test and/or a carbamazepine-10,11 epoxide test may rarely be requested with the total carbamazepine test when a doctor wants to evaluate their contribution to drug therapy.
Patients should talk to their doctor about the timing of the sample collection. Often, the recommended time is just before the next dose is taken (“trough level”).
What does the test result mean?
The usual therapeutic range for carbamazepine when it is taken by itself is about 4 – 12 mg/L. Levels above 15 mg/L are considered toxic but ranges vary slightly from laboratory to laboratory, and may be expressed in other units such as umol/L. Doctors and patients should use the therapeutic ranges and units that have been established by the laboratory that performs the patient’s test.
Within the therapeutic range, most people will respond to the drug without excessive side effects; however, response varies with each individual. Some people will experience persistence of seizures, mood swings, or nerve pain at the low end of the therapeutic range while some people will experience excessive side effects at the upper end. Variations in free carbamazepine and carbamazepine-10,11 epoxide levels can contribute to this response. Patients should work with their doctor to find the dosage and concentration that works the best for them.
In general, if carbamazepine test results are within the therapeutic range and the patient is not having recurrent seizures, mood swings, or nerve pain and is not experiencing significant side effects, then the dosage of drug the patient is receiving is considered adequate. Patients should not increase, decrease, or stop taking their medication without consulting their doctor as it can increase their risk of having a seizure and may affect other medications that they are taking. Dosage determinations and adjustments must be evaluated on a case-by-case basis.
Is there anything else I should know?
Carbamazepine can affect or be affected by many prescribed and over-the-counter medications – such as paracetamol, warfarin, fluoxetine, isoniazid, theophylline, erythromycin, ethosuximide, and benzodiazepines. Also, the metabolism of carbamazepine can be increased by drugs such as phenobarbital, primidone and phenytoin. The effect of this increased metabolism is to decrease carbamazepine concentrations in the blood. Some of these drugs may also require monitoring with blood tests. Herbal supplements, such as St. John’s Wort, can also affect carbamazepine concentrations. Tell your doctor about all medication and supplements that you are taking.
Carbamazepine can increase the risk of certain birth defects and foetal death, and can decrease the effectiveness of oral contraceptives. Women of childbearing age should talk to their doctors about this.
How long will I need to be on carbamazepine?
Patients who have a seizure disorder, bipolar disorder, or chronic nerve pain will typically take carbamazepine or other medications throughout their lifetime. If carbamazepine ceases to be effective or causes adverse effects then the patient may need to be given different drug(s). If someone has seizures that are caused by a temporary condition then they may only need the medication for a short period of time.
Will my doctor request free carbamazepine or carbamazepine-10,11 epoxide frequently?
Elsewhere On The Web
Epilepsy Action – Treatment with epilepsy medicine
Epilepsy Society – medication for adults with epilepsy
NHS Choices: Epilepsy treatment
NHS Choices: Carbamazepine for mood disorders
NHS Choices: trigeminal neuralgia